Origins of myelodysplastic syndromes after aplastic anemia.
作者信息
Negoro Eiju, Nagata Yasunobu, Clemente Michael J, Hosono Naoko, Shen Wenyi, Nazha Aziz, Yoshizato Tetsuichi, Hirsch Cassandra, Przychodzen Bartlomiej, Mahfouz Reda Z, Kuzmanovic Teodora, Sekeres Mikkael A, Makishima Hideki, Ogawa Seishi, Maciejewski Jaroslaw P
机构信息
Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.
Department of Hematology and Oncology, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.
出版信息
Blood. 2017 Oct 26;130(17):1953-1957. doi: 10.1182/blood-2017-02-767731. Epub 2017 Sep 11.
Abstract
摘要
相似文献
1
Origins of myelodysplastic syndromes after aplastic anemia.再生障碍性贫血后骨髓增生异常综合征的起源
Blood. 2017 Oct 26;130(17):1953-1957. doi: 10.1182/blood-2017-02-767731. Epub 2017 Sep 11.
2
3
[Anemia with aplastic anemia, paroxysmal nocturnal hemoglobinuria and myelodysplastic syndromes].伴有再生障碍性贫血、阵发性睡眠性血红蛋白尿症和骨髓增生异常综合征的贫血
Ther Umsch. 2010 May;67(5):251-5. doi: 10.1024/0040-5930/a000045.
4
Sequential development of myelodysplasia and paroxysmal nocturnal hemoglobinuria in a patient with preceding aplastic anemia.
Int J Hematol. 1997 Feb;65(2):187-9.
5
Late clonal diseases of treated aplastic anemia.治疗后再生障碍性贫血的晚期克隆性疾病。
Semin Hematol. 2000 Jan;37(1):91-101.
6
IPSS-M in myelodysplastic neoplasms arising from aplastic anemia and paroxysmal nocturnal hemoglobinuria.再生障碍性贫血和阵发性睡眠性血红蛋白尿所致骨髓增生异常肿瘤中的国际预后评分系统-骨髓（IPSS-M）
Blood. 2023 Jun 22;141(25):3122-3125. doi: 10.1182/blood.2023020108.
7
Flowcytometric detection of PNH defect in Indian patients with aplastic anemia and myelodysplastic syndromes.流式细胞术检测印度再生障碍性贫血和骨髓增生异常综合征患者的阵发性睡眠性血红蛋白尿缺陷
Am J Hematol. 2000 Nov;65(3):264-5. doi: 10.1002/1096-8652(200011)65:3<264::aid-ajh17>3.0.co;2-l.
8
Cell cycling stress in the monocyte line as a risk factor for progression of the aplastic anaemia/paroxysmal nocturnal haemoglobinuria syndrome to myelodysplastic syndrome.单核细胞系中的细胞周期应激作为再生障碍性贫血/阵发性睡眠性血红蛋白尿综合征进展为骨髓增生异常综合征的一个危险因素。
Acta Haematol. 2000;103(1):33-40. doi: 10.1159/000041002.
9
Clonal evolution in aplastic anemia.再生障碍性贫血中的克隆进化。
Hematology Am Soc Hematol Educ Program. 2011;2011:90-5. doi: 10.1182/asheducation-2011.1.90.
10
Clinical spectrum and clonal evolution in germline syndromes with predisposition to myeloid neoplasms.易患髓系肿瘤的胚系综合征的临床谱和克隆演变
Br J Haematol. 2018 Jul;182(1):141-145. doi: 10.1111/bjh.14746. Epub 2017 May 9.
引用本文的文献
1
Identification of common hub genes and construction of immune regulatory networks in aplastic anemia, myelodysplastic syndromes, and acute myeloid leukemia.再生障碍性贫血、骨髓增生异常综合征和急性髓系白血病中常见枢纽基因的鉴定及免疫调节网络的构建
Front Immunol. 2025 May 8;16:1547289. doi: 10.3389/fimmu.2025.1547289. eCollection 2025.
2
Hematopoietic stem cell transplantation and immunosuppressive therapy: implications of clonal haematopoiesis.造血干细胞移植与免疫抑制治疗：克隆性造血的影响
Ann Hematol. 2025 Mar;104(3):1877-1886. doi: 10.1007/s00277-024-06152-6. Epub 2025 Jan 28.
3
Origins of T-cell-mediated autoimmunity in acquired aplastic anaemia.获得性再生障碍性贫血中T细胞介导的自身免疫的起源。
Br J Haematol. 2025 Apr;206(4):1035-1053. doi: 10.1111/bjh.19993. Epub 2025 Jan 21.
4
Myelodysplastic syndrome occurring after enfortumab vedotin treatment for metastatic urothelial carcinoma.在接受恩杂鲁胺治疗转移性尿路上皮癌后发生的骨髓增生异常综合征。
IJU Case Rep. 2024 Jun 10;7(4):316-319. doi: 10.1002/iju5.12734. eCollection 2024 Jul.
5
The state of the art in the treatment of severe aplastic anemia: immunotherapy and hematopoietic cell transplantation in children and adults.重度再生障碍性贫血的治疗现状：儿童和成人的免疫疗法与造血细胞移植
Front Immunol. 2024 Apr 5;15:1378432. doi: 10.3389/fimmu.2024.1378432. eCollection 2024.
6
Reference guide for the diagnosis of adult primary immune thrombocytopenia, 2023 edition.成人原发性免疫性血小板减少症诊断参考指南，2023 年版。
Int J Hematol. 2024 Jan;119(1):1-13. doi: 10.1007/s12185-023-03672-1. Epub 2023 Nov 13.
7
Genomics of deletion 7 and 7q in myeloid neoplasm: from pathogenic culprits to potential synthetic lethal therapeutic targets.骨髓增生异常肿瘤中缺失 7 和 7q 的基因组学：从致病元凶到潜在的合成致死治疗靶点。
Leukemia. 2023 Oct;37(10):2082-2093. doi: 10.1038/s41375-023-02003-x. Epub 2023 Aug 26.
8
Clonal evolution in aplastic anemia: failed tumor surveillance or maladaptive recovery?再生障碍性贫血中的克隆进化：肿瘤监测失败还是适应性恢复不良？
Leuk Lymphoma. 2023 Jul-Aug;64(8):1389-1399. doi: 10.1080/10428194.2023.2215614. Epub 2023 Jun 25.
9
Clinical implications of myeloid malignancy‑related somatic mutations in aplastic anemia.骨髓增生异常相关体细胞突变在再生障碍性贫血中的临床意义。
Clin Exp Med. 2023 Dec;23(8):4473-4482. doi: 10.1007/s10238-023-01067-4. Epub 2023 Apr 22.
10
Epigenetic regulation by ASXL1 in myeloid malignancies.ASXL1 在髓系恶性肿瘤中的表观遗传调控。
Int J Hematol. 2023 Jun;117(6):791-806. doi: 10.1007/s12185-023-03586-y. Epub 2023 Apr 16.
本文引用的文献
1
Dynamics of clonal evolution in myelodysplastic syndromes.骨髓增生异常综合征的克隆进化动力学
Nat Genet. 2017 Feb;49(2):204-212. doi: 10.1038/ng.3742. Epub 2016 Dec 19.
2
Somatic Mutations and Clonal Hematopoiesis in Aplastic Anemia.再生障碍性贫血中的体细胞突变与克隆性造血
N Engl J Med. 2015 Jul 2;373(1):35-47. doi: 10.1056/NEJMoa1414799.
3
Genetic characterization of acquired aplastic anemia by targeted sequencing.通过靶向测序对获得性再生障碍性贫血进行基因特征分析。
Haematologica. 2014 Sep;99(9):e165-7. doi: 10.3324/haematol.2013.101642. Epub 2014 Jun 6.
4
Low frequency clonal mutations recoverable by deep sequencing in patients with aplastic anemia.再生障碍性贫血患者中可通过深度测序检测到的低频克隆性突变。
Leukemia. 2013 Apr;27(4):968-71. doi: 10.1038/leu.2013.30. Epub 2013 Feb 1.
5
Frequent loss of HLA alleles associated with copy number-neutral 6pLOH in acquired aplastic anemia.获得性再生障碍性贫血中与拷贝数中性 6pLOH 相关的 HLA 等位基因频繁缺失。
Blood. 2011 Dec 15;118(25):6601-9. doi: 10.1182/blood-2011-07-365189. Epub 2011 Sep 30.
6
Mutations of an E3 ubiquitin ligase c-Cbl but not TET2 mutations are pathogenic in juvenile myelomonocytic leukemia.E3 泛素连接酶 c-Cbl 的突变而非 TET2 突变是青少年骨髓单核细胞白血病的致病因素。
Blood. 2010 Mar 11;115(10):1969-75. doi: 10.1182/blood-2009-06-226340. Epub 2009 Dec 11.
7
Application of array-based whole genome scanning technologies as a cytogenetic tool in haematological malignancies.基于芯片的全基因组扫描技术作为细胞遗传学工具在血液系统恶性肿瘤中的应用。
Br J Haematol. 2009 Sep;146(5):479-88. doi: 10.1111/j.1365-2141.2009.07757.x. Epub 2009 Jun 26.
8
Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS/MPD, and MDS-derived AML.通过单核苷酸多态性（SNP）阵列在骨髓增生异常综合征（MDS）、骨髓增生异常/骨髓增殖性疾病（MDS/MPD）及MDS衍生的急性髓系白血病（AML）中检测到的染色体病变和单亲二体。
Blood. 2008 Feb 1;111(3):1534-42. doi: 10.1182/blood-2007-05-092304. Epub 2007 Oct 22.
9
Distinct clinical outcomes for cytogenetic abnormalities evolving from aplastic anemia.再生障碍性贫血演变而来的细胞遗传学异常的不同临床结局。
Blood. 2002 May 1;99(9):3129-35. doi: 10.1182/blood.v99.9.3129.
10
Relationship between bone marrow failure syndromes and the presence of glycophosphatidyl inositol-anchored protein-deficient clones.骨髓衰竭综合征与糖基磷脂酰肌醇锚定蛋白缺陷克隆存在之间的关系。
Br J Haematol. 2001 Dec;115(4):1015-22. doi: 10.1046/j.1365-2141.2001.03191.x.
Zotero 插件